TVTX Q4 2021 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$57M+12.3% YoY

Gross Profit

$55M96.7% margin

Operating Income

-$47M-82.4% margin

Net Income

-$52M-90.1% margin

EPS (Diluted)

$-0.84

QoQ Revenue Growth

-16.1%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$32M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$777M

Total Liabilities

$475M

Stockholders' Equity

$302M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$51M	+12.3%
Gross Profit	$55M	$49M	+13.2%
Operating Income	-$47M	-$119M	+60.2%
Net Income	-$52M	-$122M	+57.6%

Revenue Segments

Product

$55M95%

License

$3M5%